FENNEC PHARMACEUTICALS INC. - Director's Dealing 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-11-16

Reporting Person: Islam Khalid (N/A)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-16	Common Shares	M	133333	$2.31	Acquired	133333	Direct
2023-11-16	Common Shares	M	10000	$2.69	Acquired	143333	Direct
2023-11-16	Common Shares	M	50000	$1.13	Acquired	193333	Direct
2023-11-16	Common Shares	M	20492	$2.44	Acquired	213825	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-16	Common Shares	$2.31	M	133333	Disposed	2024-04-25	Options (133333)	Direct
2023-11-16	Common Shares	$2.69	M	10000	Disposed	2024-12-31	Options (10000)	Direct
2023-11-16	Common Shares	$1.13	M	50000	Disposed	2025-12-11	Options (50000)	Direct
2023-11-16	Common Shares	$2.44	M	20492	Disposed	2026-06-09	Options (20492)	Direct

F1: Shares acquired through the exercise of an option contract with a strike of $2.31 and an expiration date of April 25, 2024.

F2: Shares acquired through the exercise of an option contract with a strike of $2.69 and an expiration date of December 31, 2024.

F3: Shares acquired through the exercise of an option contract with a strike of $1.13 and an expiration date of December 11, 2025.

F4: Shares acquired through the exercise of an option contract with a strike of $2.44 and an expiration date of June 9, 2026.

F5: Represents options granted on April 25, 2014, with a strike price of $2.31 and an expiration date of April 25, 2024.

F6: Represents options granted on December 31, 2014, with a strike price of $2.69 and an expiration date of December 31, 2024.

F7: Represents options granted on December 11, 2015, with a strike price of $1.13 and an expiration date of December 11, 2025.

F8: Represents options granted on June 9, 2016, with a strike price of $2.44 and an expiration date of June 9, 2026.